Moreover, PKM2 has been shown to regulate the metabolic skewing of Th17 cells, and cell-specific PKM2 knockout effectively ameliorates hepatic inflammation and NAFLD [41]. This evidence concerns the gene PKM and metabolic dysfunction-associated steatotic liver disease.